Clinical Trial Update: The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation [Phase 3]

View source ↗

Summary

A Phase 3 trial update on using ketamine and dexmedetomidine for sedation in intensive care patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness in Icu
• Sedation-related Management in Intensive Care

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ketamine (ketamine)

Snippet

Sponsor: Lebanese American University Medical Center | Conditions: ICU Patients, Sedation | Phase 3 | Status: UNKNOWN